Rhode Island Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 6 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 13,464
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 70.41%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 4,671
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 78.02%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 24.03% 17.66%
White, Hispanic/Latino Patients 22.30% 24.60%
Black/African American, Non-Hispanic/Latino Patients 6.75% 5.91%
Black/African American, Hispanic/Latino Patients 2.92% 3.32%
Asian Patients3 1.57% 1.54%
American Indian/Alaska Native Patients3 0.23% 0.30%
Native Hawaiian/Other Pacific Islander Patients3 0.66% 0.47%
Patients with More Than One Race3 8.15% 9.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 14.62% 17.34%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.29% 2.53%
Unreported/Refused to Report Race and Ethnicity 16.48% 17.11%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 502
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 66.30%
COVID-19 Immunization Series Completed 472
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 60.73%
COVID-19 Immunization Series Additional 960
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 43.56%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 30.88% 34.11% 52.92%
White, Hispanic/Latino Patients 20.92% 16.74% 10.42%
Black/African American, Non-Hispanic/Latino Patients 6.18% 6.78% 8.02%
Black/African American, Hispanic/Latino Patients 3.59% 1.48% 1.15%
Asian Patients3 2.79% 2.33% 4.27%
American Indian/Alaska Native Patients3 0.20% 0.42% 0.52%
Native Hawaiian/Other Pacific Islander Patients3 1.99% 1.48% 0.62%
Patients with More Than One Race3 7.17% 5.08% 4.90%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 17.93% 18.43% 10.94%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.39% 3.81% 3.23%
Unreported/Refused to Report Race and Ethnicity 5.98% 9.32% 3.02%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 16.67%
1 to 24 Hours 0.00%
More Than 24 Hours 83.33%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 50.00%
Vaccine confidence 16.67%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 33.33%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 42.50%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 33.33%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 4
Number of School-Based Vaccination Sites 30
Number of Family Vaccination Clinics 30

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 16.67%
Refer patients to another organization that provides monoclonal antibody therapies 33.33%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 50.00%
Therapy administration/onsite logistics 16.67%
Other 0.00%
None 50.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 1
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 2,250

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 0.00%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 100.00%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022